Back to dashboard
MedicaidCoverageMedium impact

23-1321m Help Protect Infants with Nirsevimab at No Cost through VFC Program

Health Net·CA · Pediatrics, OB-GYN·Provider News
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply
—

Summary

Nirsevimab (Beyfortus™) for RSV prevention in infants is now available at no cost through California's VFC Program, saving facilities $495 per dose. Birthing and pediatric hospitals serving Medi-Cal members should enroll in the VFC Program to provide this immunization at no cost.

Action Required

Action needed
Immediately: Birthing and pediatric hospitals serving Medi-Cal members should enroll in California VFC Program at eziz website or call 877-243-8832 for enrollment support. This enables facilities to obtain Nirsevimab at no cost instead of paying $495 per dose for RSV prevention in infants.

Related policy hubs